Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access

FDA Panel Says COX-2 Inhibitors Should Not Be Withdrawn, Although Risks Must Be Clearly Disclosed to Patients

Topics in Pain Management: April 2005 - Volume 20 - Issue 9 - p 9
  • Buy
Copyright © 2005 Wolters Kluwer Health, Inc. All rights reserved.